Clinical Trials Directory

Trials / Completed

CompletedNCT02664246

Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method

Chinese People's Liberation Army General Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
10,000 (actual)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This review article have included about ten thousand patients undergoing percutaneous coronary intervention (PCI), aim to identify the incidence of CIN in actual, find some new risk factors and the protecting methods for these factors.

Detailed description

About ten thousand patients undergoing percutaneous coronary intervention (PCI) from 2010 to 2015 are included in this study. We collect the data about the SCr of the patients before and after percutaneous coronary intervention, and define CIN as an increase in SCr of 0.5 mg/dl or 25% from baseline between 48 and 72 h after contrast medium exposure. Besides we obtain the data including clinical characteristics, laboratory data (blood and urine tests) for all the patients. The statistical analysis will find some new risk factors.

Conditions

Interventions

TypeNameDescription
DEVICEpercutaneous coronary intervention

Timeline

Start date
2015-01-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2016-01-27
Last updated
2016-01-27

Source: ClinicalTrials.gov record NCT02664246. Inclusion in this directory is not an endorsement.